ey0017.3-15 | Medication associated thyroid disease | ESPEYB17
B Barrett , CP Hawkes , A Isaza , AJ Bauer
ey0015.3-14 | ATA Scientific statement | ESPEYB15
AM Leung , AJ Bauer , S Benvenga , AV Brenner , JV Hennessey , JR Hurley , SA Milan , AB Schneider , K Sundaram , DJ Toft
ey0020.1-12 | Autoimmune Thyroid Disease | ESPEYB20
S Halada , JA Baran , A Isaza , T Patel , L Sisko , K Kazahaya , NS Adzick , WR Katowitz , L Magee , AJ Bauer
ey0019.9-2 | Thyroid cancer in childhood cancer survivors | ESPEYB19
Remortel BJ Van , L Chehab , AJ Bauer , A Isaza , L Yimei , HD Baumgarten , AT Franco , TW Laetsch , K Kazahaya , NS Adzick , S Mostoufi-Moab
ey0021.9-11 | Thyroid Issues in Cancer Survivors | ESPEYB21
JA Baran , S Halada , AJ Bauer , Y Li , A Isaza , T Patel , L Sisko , JP Ginsberg , K Kazahaya , NS Adzick , S Mostoufi-Moab
ey0019.3-14 | Paediatric thyroid cancer | ESPEYB19
AT Franco , JC Ricarte-Filho , A Isaza , Z Jones , N Jain , S Mostoufi-Moab , L Surrey , TW Laetsch , MM Li , JC DeHart , E Reichenberger , D Taylor , K Kazahaya , NS Adzick , AJ Bauer